Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-04-13

FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)

View source ↗

Summary

The FDA approved a supplemental application for LANTUS SOLOSTAR (insulin glargine) submitted by Sanofi‑Aventis U.S. LLC, authorizing changes under a supplementa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lantus SoloStar (Insulin glargine)

Snippet

SUPPL AP for LANTUS SOLOSTAR (INSULIN GLARGINE)